| Detected | Trial | Change |
|---|---|---|
| 2026-07-31 | NCT06947304 Evaluation of Miricorilant on Liver Fat in Patients With MASLD |
Enrollment closed, study ongoing |
| 2026-07-31 | NCT06947304 Evaluation of Miricorilant on Liver Fat in Patients With MASLD |
Enrollment increased: 8 -> 9 participants |
| 2026-07-31 | NCT06947304 Evaluation of Miricorilant on Liver Fat in Patients With MASLD |
date change Primary completion pushed: 2026-05 -> 2026-08 |
| 2026-07-31 | NCT06947304 Evaluation of Miricorilant on Liver Fat in Patients With MASLD |
date change Completion pushed: 2026-05 -> 2026-09 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05257408 | Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant… | Ovarian Neoplasm | Active, Not Recruiting |
| Phase 2 | |||
| NCT05407324 | Dazucorilant in Patients With Amyotrophic Lateral Sclerosis | Amyotrophic Lateral Sclerosis | Recruiting |
| NCT07259317 | Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic… | Adenocarcinoma | Recruiting |
| NCT06906341 | Relacorilant in Combination With Different Treatment Regimens in Patients With… | Ovarian Cancer | Recruiting |
| NCT06108219 | A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic… | Nonalcoholic Steatohepatitis (NASH) | Active, Not Recruiting |
| NCT03604198 | Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With… | Cushing Syndrome | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT07276373 | Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid… | Neoplasms | Recruiting |
| Phase 1 | |||
| NCT07553663 | Evaluating the Pharmacokinetics and Safety of Miricorilant | Nonalcoholic Steatohepatitis (NASH) | Recruiting |
| NCT06947304 | Evaluation of Miricorilant on Liver Fat in Patients With MASLD | Nonalcoholic Steatohepatitis (NASH) | Active, Not Recruiting |